ARCTArcturus Therapeutics Holdings Inc.
$9.83-15% 1Y
$9.83
$5.5252 weeks$16.96
Is the price fair?
What ARCT's price assumes
Arcturus Therapeutics Holdings Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 6.50× revenue.
6.50
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.11
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 1.11
- EV / EBIToperating margin −348%: the multiple describes the denominator
- not meaningful
- Market capitalisation28.4 million shares, counted Aug 4, 2026
- $279M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.